The use of genetic programming in the analysis of quantitative gene expression profiles for identification of nodal status in bladder cancer
about
Molecular substratification of bladder cancer: moving towards individualized patient managementApplications of genetic programming in cancer researchAssessing the mechanism and therapeutic potential of modulators of the human Mediator complex-associated protein kinasesTumor-suppressive effects of CDK8 in endometrial cancer cells.Generation of a concise gene panel for outcome prediction in urinary bladder cancer.Comparative genome analysis of a large Dutch Legionella pneumophila strain collection identifies five markers highly correlated with clinical strainsRe: Joseph Chin. In Search of the Perfect Crystal Ball for Ta Urothelial Cancer. Eur Urol. doi:10.1016/j.eururo.2009.09.014.Predicting recurrence and progression of noninvasive papillary bladder cancer at initial presentation based on quantitative gene expression profiles.Expression profiling for bladder cancer: strategies to uncover prognostic factors.Ancestral genome inference using a genetic algorithm approachFeature selection and molecular classification of cancer using genetic programmingGeneration and external validation of a tumor-derived 5-gene prognostic signature for recurrence of lymph node-negative, invasive colorectal carcinoma.Combination of molecular alterations and smoking intensity predicts bladder cancer outcome: a report from the Los Angeles Cancer Surveillance Program.A novel precision-engineered microfiltration device for capture and characterisation of bladder cancer cells in urineA genetic programming approach to oral cancer prognosis.MiRNA-26b inhibits cellular proliferation by targeting CDK8 in breast cancerMolecular signatures that predict nodal metastasis in bladder cancer: does the primary tumor tell tales?Prognostic value of cell-cycle regulation biomarkers in bladder cancer.ANXA5 level is linked to in vitro and in vivo tumor malignancy and lymphatic metastasis of murine hepatocarcinoma cell.Oncolytic virotherapy for urological cancers.Cdk8 deletion in the Apc(Min) murine tumour model represses EZH2 activity and accelerates tumourigenesis.Aberrant expression of CDK8 regulates the malignant phenotype and associated with poor prognosis in human laryngeal squamous cell carcinoma.Inhibitors of cyclin-dependent kinases as cancer therapeutics.Fine-tuning of histone H3 Lys4 methylation during pseudohyphal differentiation by the CDK submodule of RNA polymerase II.Discovery of a Covalent Kinase Inhibitor from a DNA-Encoded Small-Molecule Library × Protein Library Selection.
P2860
Q26744343-082E8DA3-B4F0-44BE-9469-98AC6DBEB51DQ28731403-F1A0C69B-7E1B-4CCE-9AB1-B4530864B1CEQ28817622-0D38EA7F-6675-4874-8CB9-6EBB640D462FQ30539219-E027F092-AA97-478B-AC43-50D169792360Q33561596-B99121A8-7E41-41B4-8CD8-A83FD5679528Q33632756-C43E774D-9BBE-4880-A1DD-BCF4B2652E58Q33687900-35A67A89-0146-4069-9E4B-C69FF2CD1ABBQ33687975-076C7B0E-EF57-4887-96C2-DEA4B1051CDBQ34537170-E3693BF1-3F32-43D7-BBA9-50F8229D1BBBQ34712424-4384863E-48F3-4876-8607-41CFD5E7591AQ35756955-A6E34D3B-C61E-4E7A-9B98-5806D878C23BQ36494944-063BA903-F368-44C6-9771-676AB6231CBEQ36589325-B4F54E4B-5D72-4113-AB3F-77F6F99E9B2CQ37209662-4084564F-CFA3-46A8-B6FB-A2910F7E4F44Q37282178-AE497BBA-2E1F-43D4-8E5C-F5A46DD6FE62Q37711440-9B09C75D-03C0-4E30-8429-72E5C53B1238Q37894668-E3BF7DAC-2CC5-4AA8-90A7-2A5CC1BD332DQ38049692-6324E541-0687-4088-8EA6-2E06446AD642Q38816095-20E095EA-A36F-41C5-B150-7221C905859EQ38842126-F959A7E9-F9FE-4747-B37D-F3C4702C8FCDQ38847178-25057351-D669-4519-B01A-03248AD43264Q38950983-9CC4C0AC-24B4-4BB7-9FBF-0DC25C31F0E7Q39125016-534FBF9A-5257-41CE-89DF-F9D9E67DBE79Q43132772-2E644D13-5C86-47D4-8261-326304BB0324Q48156085-CFE6BA50-9356-4DA0-97C3-D1548E660D8A
P2860
The use of genetic programming in the analysis of quantitative gene expression profiles for identification of nodal status in bladder cancer
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
The use of genetic programming ...... nodal status in bladder cancer
@ast
The use of genetic programming ...... nodal status in bladder cancer
@en
type
label
The use of genetic programming ...... nodal status in bladder cancer
@ast
The use of genetic programming ...... nodal status in bladder cancer
@en
prefLabel
The use of genetic programming ...... nodal status in bladder cancer
@ast
The use of genetic programming ...... nodal status in bladder cancer
@en
P2093
P2860
P356
P1433
P1476
The use of genetic programming ...... nodal status in bladder cancer
@en
P2093
Arpit A Almal
Ben George
David W Fry
Peter F Lenehan
Ram H Datar
Richard J Cote
Vincenzo Pagliarulo
William P Worzel
P2860
P2888
P356
10.1186/1471-2407-6-159
P407
P577
2006-06-16T00:00:00Z
P5875
P6179
1025606751